These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 25701862)

  • 1. ISFM consensus guidelines on the practical management of diabetes mellitus in cats.
    Sparkes AH; Cannon M; Church D; Fleeman L; Harvey A; Hoenig M; Peterson ME; Reusch CE; Taylor S; Rosenberg D;
    J Feline Med Surg; 2015 Mar; 17(3):235-50. PubMed ID: 25701862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feline diabetes mellitus: clinical use of long-acting glargine and detemir.
    Bloom CA; Rand J
    J Feline Med Surg; 2014 Mar; 16(3):205-15. PubMed ID: 24563492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of detemir in diabetic cats managed with a protocol for intensive blood glucose control.
    Roomp K; Rand J
    J Feline Med Surg; 2012 Aug; 14(8):566-72. PubMed ID: 22553309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin detemir treatment in diabetic cats in a practice setting.
    Hoelmkjaer KM; Spodsberg EM; Bjornvad CR
    J Feline Med Surg; 2015 Feb; 17(2):144-51. PubMed ID: 24938314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (Ultra-)long-acting insulin analogues for people with type 1 diabetes mellitus.
    Hemmingsen B; Metzendorf MI; Richter B
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013498. PubMed ID: 33662147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Newer agents for blood glucose control in type 2 diabetes: systematic review and economic evaluation.
    Waugh N; Cummins E; Royle P; Clar C; Marien M; Richter B; Philip S
    Health Technol Assess; 2010 Jul; 14(36):1-248. PubMed ID: 20646668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency of diabetic remission, predictors of remission and survival in cats using a low-cost, moderate-intensity, home-monitoring protocol and twice-daily glargine.
    Gottlieb S; Rand JS; Anderson ST
    J Feline Med Surg; 2024 Apr; 26(4):1098612X241232546. PubMed ID: 38661475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of diabetic cats with long-acting insulin.
    Roomp K; Rand JS
    Vet Clin North Am Small Anim Pract; 2013 Mar; 43(2):251-66. PubMed ID: 23522171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of glargine and lente insulins in cats with diabetes mellitus.
    Weaver KE; Rozanski EA; Mahony OM; Chan DL; Freeman LM
    J Vet Intern Med; 2006; 20(2):234-8. PubMed ID: 16594577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensive blood glucose control is safe and effective in diabetic cats using home monitoring and treatment with glargine.
    Roomp K; Rand J
    J Feline Med Surg; 2009 Aug; 11(8):668-82. PubMed ID: 19592286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Priorities on treatment and monitoring of diabetic cats from the owners' points of view.
    Albuquerque CS; Bauman BL; Rzeznitzeck J; Caney SM; Gunn-Moore DA
    J Feline Med Surg; 2020 Jun; 22(6):506-513. PubMed ID: 31241424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of newly diagnosed diabetic cats with glargine insulin improves glycaemic control and results in higher probability of remission than protamine zinc and lente insulins.
    Marshall RD; Rand JS; Morton JM
    J Feline Med Surg; 2009 Aug; 11(8):683-91. PubMed ID: 19539509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin detemir: a review of its use in the management of diabetes mellitus.
    Keating GM
    Drugs; 2012 Dec; 72(17):2255-87. PubMed ID: 23110609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Observational 6-month open-label study of Japanese type 2 diabetes patients switching from NPH insulin to insulin detemir in basal-bolus regimen: 23rd article of the Japan Diabetes Clinical Data Management Study Group (JDDM23).
    Oishi M; Abe N; Yokoyama H; Kuribayashi N; Tomonaga O; Matoba K; Kobayashi M;
    J Int Med Res; 2012; 40(2):787-97. PubMed ID: 22613444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ISFM Consensus Guidelines on the Diagnosis and Management of Feline Chronic Kidney Disease.
    Sparkes AH; Caney S; Chalhoub S; Elliott J; Finch N; Gajanayake I; Langston C; Lefebvre HP; White J; Quimby J
    J Feline Med Surg; 2016 Mar; 18(3):219-39. PubMed ID: 26936494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral hypoglycemics in cats with diabetes mellitus.
    Palm CA; Feldman EC
    Vet Clin North Am Small Anim Pract; 2013 Mar; 43(2):407-15. PubMed ID: 23522179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus.
    Horvath K; Jeitler K; Berghold A; Ebrahim SH; Gratzer TW; Plank J; Kaiser T; Pieber TR; Siebenhofer A
    Cochrane Database Syst Rev; 2007 Apr; (2):CD005613. PubMed ID: 17443605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current understanding of feline diabetes: part 2, treatment.
    Martin G; Rand J
    J Feline Med Surg; 2000 Mar; 2(1):3-17. PubMed ID: 11716587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Field safety and efficacy of protamine zinc recombinant human insulin for treatment of diabetes mellitus in cats.
    Nelson RW; Henley K; Cole C;
    J Vet Intern Med; 2009; 23(4):787-93. PubMed ID: 19566845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of diabetes mellitus in cats with porcine insulin zinc suspension.
    Martin GJ; Rand JS
    Vet Rec; 2007 Jul; 161(3):88-94. PubMed ID: 17652434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.